Updates

Ref: 02/SE/LC/2026-27 Date: October 23, 2026 To, To, National Stock Exchange of India Limited BSE Limited (“BSE”) (“NSE”) Listing Department Listing Department Corporate Relationship Department Exchange Plaza, C-1 Block G, Bandra Kurla Phiroze Jeejeebhoy Towers, Complex Bandra (East), Mumbai – 400051 Dalal Street, Fort, Mumbai - 400 001 NSE Scrip Symbol: SMT BSE Scrip Code: 545001 ISIN: INE356Y01018 ISIN: INE356Y01018 Subject: Disclosure under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir/ Madam, This is to inform you that pursuant to Regulation 30(5) of the Listing Regulations and in terms of the Policy for Determination of Materiality of Events or Information adopted by the Company, the following Key Managerial Personnel of the Company are authorized to determine the materiality of an event or information and to make disclosure of material events or information to the stock exchange(s): S. No. Name of Designation Email IDs Contact Details Authorized Person 1. Mr. Bhargav Managing Director & bhargav@smt.in 022 49564000 Dhirajlal Kotadia Chief Executive Officer 2. Mr. Amit Kumar Chief Financial Officer amit.khandelia@smt.in Khandelia 3. Ms. Deepshikha Company Secretary & investors.grievance@smt. Singhal Compliance Officer in The aforesaid details are also available on the company’s website at www.smtpl.com This is for your information and records. Thanking you, For Sahajanand Medical Technologies Limited Bhargav Dhirajlal Kotadia Managing Director & Chief Executive Officer DIN: 06575042